Date | Time | Source | Headline | Symbol | Company |
02/04/2010 | 9:05AM | PR Newswire (US) | ADVENTRX Announces Management Promotions | AMEX:ANX | |
02/04/2010 | 8:54AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
02/04/2010 | 8:52AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
02/03/2010 | 9:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
02/03/2010 | 9:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
02/03/2010 | 9:51PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
02/03/2010 | 9:50PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
02/03/2010 | 9:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
02/03/2010 | 9:47PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
02/03/2010 | 9:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
02/03/2010 | 9:44PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:ANX | Mast Therapeutics, Inc. |
02/03/2010 | 8:53AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
02/03/2010 | 8:00AM | PR Newswire (US) | ADVENTRX Appoints Icahn Representative to Board of Directors | AMEX:ANX | |
02/02/2010 | 8:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9 | AMEX:ANX | |
01/26/2010 | 4:03PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
01/07/2010 | 4:18PM | PR Newswire (US) | ADVENTRX Pharmaceuticals Announces Closing of Financing | AMEX:ANX | |
01/06/2010 | 8:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the OneMedForum Finance Conference on January 13 | AMEX:ANX | |
01/04/2010 | 9:33AM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | AMEX:ANX | Mast Therapeutics, Inc. |
01/04/2010 | 9:23AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
01/04/2010 | 9:20AM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | AMEX:ANX | Mast Therapeutics, Inc. |
01/04/2010 | 9:15AM | PR Newswire (US) | ADVENTRX Pharmaceuticals Announces Financing | AMEX:ANX | |
01/04/2010 | 9:11AM | Edgar (US Regulatory) | Registration of Additional Securities (up to 20%) (S-3MEF) | AMEX:ANX | Mast Therapeutics, Inc. |
01/04/2010 | 6:06AM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | AMEX:ANX | Mast Therapeutics, Inc. |
01/04/2010 | 6:02AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
01/04/2010 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals Submits ANX-530 New Drug Application | AMEX:ANX | |
12/24/2009 | 12:52PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
12/11/2009 | 6:30AM | Marketwired | Analyst Choice Scrutinizes the Basic Materials, Financial and Services Sectors | AMEX:ANX | Mast Therapeutics, Inc. |
12/09/2009 | 8:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference | AMEX:ANX | |
12/03/2009 | 7:00AM | Marketwired | Benchmark Journal Offers Fundamental Analysis of Companies in the Financial, Services and Basic Materials Sectors | AMEX:ANX | Mast Therapeutics, Inc. |
12/01/2009 | 8:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 | AMEX:ANX | |